The number of people with susceptibility test result for rifampicin in Trinidad and Tobago
Trinidad and Tobago: The number of people with susceptibility test result for rifampicin was 57 in 2021. ▼ Falling
Latest (2021)
57
Change on year
down 38.0%
World rank
120th
of 155 countries
All-time high
151
in 2018
All-time low
57
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Trinidad and Tobago, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Trinidad and Tobago is 57, measured in 2021. That is the lowest value across all 5 years on record.
That represents a change of down 38.0% on the previous year and down 14.9% over five years.
That places Trinidad and Tobago 120th out of 155 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Trinidad and Tobago, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 67 | — |
| 2018 | 151 | +125.4% |
| 2019 | 90 | -40.4% |
| 2020 | 92 | +2.2% |
| 2021 | 57 | -38.0% |
Trinidad and Tobago compared with similar countries
- Trinidad and Tobago's 57 is below the median for high income countries, which is 142, 40% of the median. (61 countries reporting)
- Trinidad and Tobago's 57 is below the median for Latin America & Caribbean, which is 406.5, 14% of the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 102.67 | 67 | 151 | 3 |
| 2020s | 74.5 | 57 | 92 | 2 |
Countries ranked near Trinidad and Tobago
More health data for Trinidad and Tobago
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1463 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,638 deaths per 1,000 people (2090)
- Number of infants who die before age 1 24 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.35 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0263 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.36 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Trinidad and Tobago?
- The number of people with susceptibility test result for rifampicin in Trinidad and Tobago was 57 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Trinidad and Tobago?
- The highest recorded value was 151 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Trinidad and Tobago?
- The lowest recorded value was 57 in 2021.
- How does Trinidad and Tobago rank for the number of people with susceptibility test result for rifampicin?
- Trinidad and Tobago ranks 120th out of 155 countries with data for 2021.
- Where does this Trinidad and Tobago data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).